PMD Device Solutions
1.32
SEK
-5.71 %
PMDS
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
-5.71%
-11.41%
-53.85%
-69.3%
-81.67%
-88.31%
-84.33%
-99.31%
-99.77%
-99.91%
investors.pmd-solutions.com/en
PMD Device Solutions develops and sells medical products for respiratory monitoring for both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is commercialised in Europe, the UK, and FDA cleared in the US.
Revenue
28.62M
EBIT %
-70.02 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PMDS
Daily low / high price
1.32 / 1.39
SEK
Market cap
34.24M SEK
Turnover
115.29K SEK
Volume
85K
Financial calendar
Interim report
2024-11-22
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Myles Murray | 38.8 % | 38.8 % |
Anne Dorney | 9.3 % | 9.3 % |
Tom O'Brien | 4.9 % | 4.9 % |
Gentian Health LTD | 4.1 % | 4.1 % |
Mohammed Al Amoudi & company | 3.7 % | 3.7 % |
Chirp AB | 2.9 % | 2.9 % |
Christopher Martin | 2.4 % | 2.4 % |
Hurley Conor | 1.8 % | 1.8 % |
Sullivan Donal | 1.6 % | 1.6 % |
Thrasherstown Farm LTD | 1.4 % | 1.4 % |
ShowingAll content types
PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report
PMDS announces last day of trading in BTA
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools